Improving the algorithm and preliminary assessment of the performance of 3D multiparametric ultrasound for the detection, grading and localization of prostate cancer

Recruiting

• Conditions: Prostate cancer; prostatic adenocarcinoma; 10038597

• Registration Number: NL-OMON56037
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 715

Inclusion Criteria

Men >=18 years with a clinical suspicion of prostate cancer or confirmed
prostate cancer.
Scheduled for either systematic and/or targeted biopsy after mpMRI examination
or radical prostatectomy

Exclusion Criteria

- No mpMRI performed prior to prostate biopsy or radical prostatectomy
- A history of chemotherapy for PCa or currently being treated with
chemotherapy for PCa.
- A patient history that includes any of the following prostate related
interventions:
o Brachytherapy or external radiotherapy for PCa;
o Focal therapy for prostate cancer;
o Prostate biopsy within the last 30 days.
- Hormonal therapy for prostate cancer within the last six months
- A patient history with a cardiac right to left shunt.
- Current treatment with dobutamine
- Known severe pulmonary hypertension (pulmonary artery pressure >90 mmHg),
uncontrolled systemic hypertension or respiratory distress syndrome
- Incapable of understanding the language in which the patient information is
given.
- Allergic reaction to previous ultrasound contrast administration.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified